Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Haile

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Breast Cancer Research and Treatment|December 17, 2010
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier statusJane C Figueiredo, Jennifer D Brooks, David V Conti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 17, 2012
Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older womenPaul J Limburg, David Limsui, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2013
Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older womenLori S Tillmans, Robert A Vierkant, Alice H Wang, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2015
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older WomenLori S Tillmans, Robert A Vierkant, Alice H Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability statusJenny N Poynter, Robert W Haile, Kimberly D Siegmund, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Breast Cancer Research and Treatment|December 17, 2010
Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier statusJane C Figueiredo, Jennifer D Brooks, David V Conti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 17, 2012
Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older womenPaul J Limburg, David Limsui, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2013
Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older womenLori S Tillmans, Robert A Vierkant, Alice H Wang, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2015
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older WomenLori S Tillmans, Robert A Vierkant, Alice H Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability statusJenny N Poynter, Robert W Haile, Kimberly D Siegmund, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Pageof 19